Click image to inspect pack details
PPI & Digestive Range Marketed by Aerochem Neutron

AEROPAN-D

Formulation Code AC-502
Commercial Status Active Product Information Available

Product Overview & Formulation Profile

Composition: Pantoprazole 40mg + Domperidone 10mg (tablets). The rationale for the combination is complementary action: Pantoprazole (proton pump inhibitor) and Domperidone (prokinetic and antiemetic).

Pantoprazole is a proton pump inhibitor that suppresses gastric acid secretion by inhibiting H+/K+-ATPase. Domperidone is a peripheral dopamine D2 antagonist with prokinetic and antiemetic activity.

AEROPAN-D is a prescription medicine from Aerochem Neutron's digestive and GI range, for use on the prescription of a registered medical practitioner.

Composition & Formulation Details

·       Contains Pantoprazole 40mg + Domperidone 10mg

·       Pantoprazole — proton pump inhibitor that suppresses gastric acid secretion by inhibiting H+/K+-ATPase

·       Domperidone — peripheral dopamine D2 antagonist with prokinetic and antiemetic activity

·       Presented as tablets

·       Prescription-only medicine

·       Gastro-oesophageal reflux disease (GERD)

·       Dyspepsia with nausea or bloating

·       Hyperacidity and heartburn

·       Note: indications reflect established uses of the individual molecules; confirm against the CDSCO-approved label for this fixed-dose combination

Safety

·       Contraindicated in patients with known hypersensitivity to any component.

·       Long-term PPI use is associated with hypomagnesaemia, vitamin B12 deficiency, bone fracture risk and C. difficile infection; exclude gastric malignancy before treatment.

·       Domperidone is associated with QT prolongation and serious ventricular arrhythmias; regulators recommend the lowest effective dose for the shortest duration and avoidance in cardiac disease, hepatic impairment and with CYP3A4 inhibitors.

·       Pregnancy and lactation: use only if the prescriber judges the benefit to outweigh the risk.

Clinical Rationale: The mechanisms and labelled uses of pantoprazole described here follow the US prescribing information (DailyMed); the EMA 2014 domperidone review limited its use to relief of nausea and vomiting at the lowest effective dose for the shortest duration because of cardiac risk. Evidence summary for Domperidone: reference verification pending. Use of the combination should follow the CDSCO-approved guidelines for this fixed-dose combination.

References 

·       DailyMed (US NLM) prescribing information – pantoprazole: https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=PANTOPRAZOLE

·       EMA – Domperidone-containing medicines referral (2014): https://www.ema.europa.eu/en/medicines/human/referrals/domperidone-containing-medicines

·       Reference verification pending for: Domperidone

Professional Product Enquiries

Verified product information, formulation specifications, and commercial supply pathways for registered healthcare professionals, institutions, and trade partners.

Product Information

Review verified active composition, strength, dosage form, and packaging details on this page.

View Specifications

Healthcare Professional Enquiry

Request formulation literature, technical specifications, or product communication from our commercial team.

Submit Product Enquiry

Commercial Supply Enquiry

Connect regarding institutional supply requirements, trade distribution, or third-party contract manufacturing.

Commercial Enquiry

Professional Product Information

This product information is intended for registered healthcare professionals, medical practitioners, and authorized distribution partners. Product manufacturing is coordinated through eligible facility partners under applicable licences.

Product Enquiry

Request Formulation Details

Request information about AEROPAN-D for professional use.

Please enter the numeric sum to verify you are a human visitor.
Approved Resources

Distributor Media

Product Image - AEROPAN-D
Product Image

AEROPAN-D — Product Image

Therapeutic Alternatives

Related Formulations

2 HUNGRY Formulation
PPI & Digestive Range

2 HUNGRY

View Formulation
MILKESIA PLUS Formulation
PPI & Digestive Range

MILKESIA PLUS

View Formulation
ZYMOZEN Formulation
PPI & Digestive Range

ZYMOZEN

View Formulation
DOZON DSR Formulation
PPI & Digestive Range

DOZON DSR

View Formulation
Product Information

Need specifications for this formulation?

Request verified product information for professional use, or send a separate business enquiry for manufacturing or partnership discussions.

WhatsApp: +91 9512047000